These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 21258021)
1. New drug and biological product approvals, 2010. Traynor K Am J Health Syst Pharm; 2011 Feb; 68(3):186, 188, 190. PubMed ID: 21258021 [No Abstract] [Full Text] [Related]
2. FDA new drug approvals in Q3 2019. Urquhart L Nat Rev Drug Discov; 2019 Oct; 18(11):816. PubMed ID: 31673140 [No Abstract] [Full Text] [Related]
3. Regulatory watch: FDA new drug approvals in Q3 2018. Urquhart L Nat Rev Drug Discov; 2018 Oct; 17(11):779. PubMed ID: 30374181 [No Abstract] [Full Text] [Related]
4. New drug and biological product approvals, 2013. Traynor K Am J Health Syst Pharm; 2014 Feb; 71(4):270. PubMed ID: 24481148 [No Abstract] [Full Text] [Related]
5. New drug and biological product approvals, 2012. Traynor K Am J Health Syst Pharm; 2013 Feb; 70(3):176, 178, 180. PubMed ID: 23327975 [No Abstract] [Full Text] [Related]
6. New drug and biological product approvals, 2011. Traynor K Am J Health Syst Pharm; 2012 Feb; 69(3):180-2. PubMed ID: 22261935 [No Abstract] [Full Text] [Related]
7. New drug and biological product approvals, 2006. Traynor K Am J Health Syst Pharm; 2007 Feb; 64(4):342, 344. PubMed ID: 17299168 [No Abstract] [Full Text] [Related]
8. New drug and biologic product approvals, 2005. Traynor K Am J Health Syst Pharm; 2006 Feb; 63(4):304, 306. PubMed ID: 16452514 [No Abstract] [Full Text] [Related]
9. New drug and biological product approvals, 2004. Traynor K Am J Health Syst Pharm; 2005 Feb; 62(4):348, 350. PubMed ID: 15745882 [No Abstract] [Full Text] [Related]
10. Accelerated approvals under the microscope. Mullard A Nat Rev Drug Discov; 2021 Jun; 20(6):409-411. PubMed ID: 34012001 [No Abstract] [Full Text] [Related]
11. New drugs and product approvals from 2000. Taylor SE; Gage TW Tex Dent J; 2001 Nov; 118(11):1070-81. PubMed ID: 11806330 [No Abstract] [Full Text] [Related]
12. FDA new drug approvals in 2009. Wynn RL Gen Dent; 2010; 58(4):280-4. PubMed ID: 20591770 [No Abstract] [Full Text] [Related]
13. FDA reveals new initiatives to deal with drug shortages. McCarthy M BMJ; 2013 Nov; 347():f6646. PubMed ID: 24188905 [No Abstract] [Full Text] [Related]
14. The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products. Berman J; Radhakrishna T Am J Trop Med Hyg; 2017 Jan; 96(1):11-13. PubMed ID: 27573627 [TBL] [Abstract][Full Text] [Related]
15. Safety in numbers--monitoring risk in approved drugs. Okie S N Engl J Med; 2005 Mar; 352(12):1173-6. PubMed ID: 15788493 [No Abstract] [Full Text] [Related]
17. FDA new drug approvals in Q1 2020. Urquhart L Nat Rev Drug Discov; 2020 May; 19(5):299. PubMed ID: 32296148 [No Abstract] [Full Text] [Related]
18. "Fast tracking" drug approvals: is consumer safety being compromised? Jacobsen K QRC Advis; 2000 Jun; 16(8):5-9. PubMed ID: 10977137 [No Abstract] [Full Text] [Related]
19. FDA new drug approvals in Q2 2021. Urquhart L Nat Rev Drug Discov; 2021 Aug; 20(8):578. PubMed ID: 34267360 [No Abstract] [Full Text] [Related]
20. The seduction of biomarkers in the practice of medicine and the tyranny of power in the drug approval process: lessons from niacin. Lehmann DF; Sitar DS J Clin Pharmacol; 2011 Nov; 51(11):1496-8. PubMed ID: 21998350 [No Abstract] [Full Text] [Related] [Next] [New Search]